Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-fluorouracil Treatment
Phase 1
- Conditions
- esophageal squamous cell carcinoma
- Registration Number
- JPRN-UMIN000010561
- Lead Sponsor
- niversity of Toyama
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria included concomitant uncontrolled diabetes mellitus, hypertension, severe heart disease, active infection, active double cancer, massive ascites, massive pleural effusion, massive pericardial effusion, active gastrointestinal tract bleeding, possible pregnancy, brain metastases with any symptoms, severe psychological disease, and tracheoesophageal fistula formation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method